by Vora Corporate Finance | Apr 20, 2024 | Insights, Merger & Acquisitions
Transaction: Biocon Biologics Limited, a fully integrated global biosimilars company and a subsidiary of Biocon Limited, today announced a long term commercial collaboration with Eris Lifesciences to expand patient access to its portfolio of Metabolics, Oncology, and...
by Vora Corporate Finance | Mar 9, 2024 | Insights, Merger & Acquisitions
Transaction: Eris Lifesciences Ltd., a leading Indian branded formulations company, today announced the expansion of its Sterile Injectable footprint through the acquisition of 51% equity stake in Swiss Parenterals Ltd. for a consideration of Rs 637.50 Crore. This...
